• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,311.20
  • 0.24 %
  • $90.57
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Cyclo Therapeutics, Inc. (CYTH) Earning

Cyclo Therapeutics, Inc. (CYTH) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$0.72

$0.03

(4.35%)

Day's range
$0.65
Day's range
$0.73

Cyclo Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.32 -$0.08 -$0.19
Q2 2024 1 -$0.25 -$0.06 -$0.16
Q3 2024 1 -$0.26 -$0.06 -$0.16
Q4 2024 2 -$0.17 -$0.15 -$0.16
Q1 2025 2 -$0.18 -$0.07 -$0.12
Q2 2025 1 -$0.33 -$0.08 -$0.20
Q3 2025 1 -$0.29 -$0.07 -$0.18
Q4 2025 1 -$0.31 -$0.07 -$0.19

Cyclo Therapeutics, Inc. Earnings Date And Information

Cyclo Therapeutics, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $-0.14 by $0.07. The company had revenue of 233,772 for the quarter and had revenue of 1.08 M for the year. Cyclo Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.23 diluted earnings per share) and currently has a price-to-earnings ratio of -0.83. Cyclo Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.

Cyclo Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/13/2024 Q3 2024 -$0.31 $294,000 $233,772
08/14/2024 Q2 2024 -$0.14 -$0.21 -0.07 $267,500 $123,104
05/15/2024 Q1 2024 -$0.20 -$0.15 0.05 $202,450
04/29/2024 Q4 2023 -$0.23 $311,399
11/14/2023 Q3 2023 -$0.29 $141,000 $495,477
08/14/2023 Q2 2023 -$0.33 $183,000 $117,118
05/12/2023 Q1 2023 -$0.46 $152,411
05/01/2023 Q4 2022 -$0.57 $186,803
11/10/2022 Q3 2022 -$0.50 $618,000 $452,167
08/15/2022 Q2 2022 -$0.41 $571,000 $541,886
05/12/2022 Q1 2022 -$0.48 $19,361.00 19361.48 $194,904
03/11/2022 Q4 2021 -$0.43 $585,115
11/15/2021 Q3 2021 -$0.67 -$0.60 0.07 $382,000 $403,918
08/16/2021 Q2 2021 -$0.56 $360,000 $238,590
05/14/2021 Q1 2021 -$0.76 $358,133
03/12/2021 Q4 2020 -$0.50 $145,586
11/12/2020 Q3 2020 -$0.85 $222,462
08/14/2020 Q2 2020 -$1.60 $209,594
05/15/2020 Q1 2020 -$2.17 $325,734
03/30/2020 Q4 2019 -$1.00 -$2.20 -1.2 $227,363
 

Cyclo Therapeutics, Inc. Earnings: Frequently Asked Questions

  • When is Cyclo Therapeutics, Inc.'s earnings date?

    Cyclo Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.

  • How can I listen to Cyclo Therapeutics, Inc.'s earnings conference call?

    The conference call for Cyclo Therapeutics, Inc.'s latest earnings report can be listened to online.

  • How can I read Cyclo Therapeutics, Inc.'s conference call transcript?

    The conference call transcript for Cyclo Therapeutics, Inc.'s latest earnings report can be read online.

  • How much revenue does Cyclo Therapeutics, Inc. generate each year?

    Cyclo Therapeutics, Inc. (:CYTH) has a recorded annual revenue of $1.08 M.

  • How much profit does Cyclo Therapeutics, Inc. generate each year?

    Cyclo Therapeutics, Inc. (:CYTH) has a recorded net income of $1.08 M. Cyclo Therapeutics, Inc. has generated $-1.23 earnings per share over the last four quarters.

  • What is Cyclo Therapeutics, Inc.'s price-to-earnings ratio?

    Cyclo Therapeutics, Inc. (:CYTH) has a price-to-earnings ratio of -0.83 and price/earnings-to-growth ratio is 0.37.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.